Cargando…

Pediatric multiple sclerosis: a review

BACKGROUND: Pediatric-onset multiple sclerosis (POMS) prevalence and incidence rates are increasing globally. No disease-modifying therapy are approved for MS pediatric population. Hence, we aim to review the literature on POMS to guide treating physicians on the current understanding of diagnosis a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alroughani, Raed, Boyko, Alexey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845207/ https://www.ncbi.nlm.nih.gov/pubmed/29523094 http://dx.doi.org/10.1186/s12883-018-1026-3

Ejemplares similares

Improving communication with multiple sclerosis patients
por: Alroughani, Raed A.
Publicado: (2015)

A matched case-control study of risk factors associated with multiple sclerosis in Kuwait
por: El-Muzaini, Hadeel, et al.
Publicado: (2020)

Replication analysis of variants associated with multiple sclerosis risk
por: Dashti, Mohammad, et al.
Publicado: (2020)

Economic burden of multiple sclerosis on Kuwait health care system
por: Alowayesh, Maryam S., et al.
Publicado: (2019)

Effectiveness and Safety of Dimethyl Fumarate Treatment in Relapsing Multiple Sclerosis Patients: Real-World Evidence
por: Alroughani, Raed, et al.
Publicado: (2017)

Impact of the first Gulf war on multiple sclerosis risk in Kuwait: a quasi-experimental study
por: Akhtar, Saeed, et al.
Publicado: (2023)

Status migrainosus as an initial presentation of multiple sclerosis
por: Alroughani, Raed, et al.
Publicado: (2015)

Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
por: Alroughani, Raed, et al.
Publicado: (2016)

Correction to: A matched case-control study of risk factors associated with multiple sclerosis in Kuwait
por: El-Muzaini, Hadeel, et al.
Publicado: (2020)

Impact of coronavirus disease (COVID-19) pandemic on multiple sclerosis care
por: Salama, Sara, et al.
Publicado: (2020)

Association of Multiple Sclerosis and COVID-19 Infection: A Case Report
por: Ismail, Ismail Ibrahim, et al.
Publicado: (2022)

Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis
por: Alroughani, Raed, et al.
Publicado: (2021)

The FTO gene polymorphism rs9939609 is associated with obesity and disability in multiple sclerosis patients
por: Al-Serri, Ahmad, et al.
Publicado: (2019)

Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis
por: Behbehani, Raed, et al.
Publicado: (2017)

COVID-19 Vaccination in People with Multiple Sclerosis. the Kuwait Experience
por: Alroughani, Raed, et al.
Publicado: (2022)

Spinal segmental myoclonus as an unusual presentation of multiple sclerosis
por: Alroughani, Raed Abdullah, et al.
Publicado: (2015)

Non-parametric analysis of seasonality in birth and multiple sclerosis risk in second generation of migrants in Kuwait
por: Akhtar, Saeed, et al.
Publicado: (2014)

A case report of multiple sclerosis after COVID-19 infection: causality or coincidence?
por: Ismail, Ismail Ibrahim, et al.
Publicado: (2021)

COVID-19 vaccination in people with multiple sclerosis, real-life experience
por: Alroughani, Raed, et al.
Publicado: (2022)

MENACTRIMS practice guideline for COVID-19 vaccination in patients with multiple sclerosis
por: Yamout, Bassem I, et al.
Publicado: (2021)

Prevalence of Anti-JC Virus Antibody in Multiple Sclerosis Patients in Kuwait
por: Lamdhade, S., et al.
Publicado: (2014)

ZFAT gene variant association with multiple sclerosis in the Arabian Gulf population: A genetic basis for gender-associated susceptibility
por: Bourguiba-Hachemi, Sonia, et al.
Publicado: (2016)

Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region
por: Alroughani, Raed, et al.
Publicado: (2020)

Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East
por: Achiron, Anat, et al.
Publicado: (2017)

Multiple Sclerosis Relapses Following Cessation of Fingolimod
por: Malpas, Charles B., et al.
Publicado: (2022)

Incidence, Severity, Outcomes, and Risk Factors of COVID-19 in Multiple Sclerosis: An Observational Study in the Middle East
por: Alroughani, Raed, et al.
Publicado: (2022)

Prevalence, severity, outcomes, and risk factors of COVID-19 in multiple sclerosis: An observational study in the Middle East
por: Alroughani, Raed, et al.
Publicado: (2022)

Effect of Dimethyl Fumarate vs Interferon β-1a in Patients With Pediatric-Onset Multiple Sclerosis: The CONNECT Randomized Clinical Trial
por: Vermersch, Patrick, et al.
Publicado: (2022)

A regional consensus recommendation on brain atrophy as an outcome measure in multiple sclerosis
por: Alroughani, Raed, et al.
Publicado: (2016)

Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential?
por: Melnikov, Mikhail, et al.
Publicado: (2021)

Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies
por: Boyko, Alexey, et al.
Publicado: (2020)

Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria
por: Alroughani, R., et al.
Publicado: (2012)

Future of Management of Multiple Sclerosis in the Middle East: A Consensus View from Specialists in Ten Countries
por: Aljumah, Mohammed, et al.
Publicado: (2013)

Cladribine tablets’ potential role as a key example of selective immune reconstitution therapy in multiple sclerosis
por: Boyko, Alexey N, et al.
Publicado: (2018)

An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion
por: Alroughani, Raed, et al.
Publicado: (2019)

Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait
por: Alroughani, R., et al.
Publicado: (2013)

Pediatric multiple sclerosis
por: Patel, Yashma, et al.
Publicado: (2009)

Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19
por: Inshasi, Jihad, et al.
Publicado: (2021)

The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
por: Alroughani, Raed, et al.
Publicado: (2020)

Alemtuzumab: A new therapy for active relapsing–remitting multiple sclerosis
por: Hartung, Hans-Peter, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6631q8cfban6q318oihiokmihh